Welcome to Nutraceuticals World   
October 2014 Issue
Last Updated Thursday, October 23 2014
Print

Columns

Nutraceuticals Multiverse: Proprietary Puncture: Part II
Anthony Almada
November 1, 2011
Proprietary compositions and “blends” enjoy partial insulation...but what if regulatory agencies and consumers could dereplicate them?  Read More »
Healthcare Practitioner Corner: Getting Weirder—and Possibly Better—By The Minute
Erik Goldman
October 1, 2011
We’re not going to improve the health of our country by counting pills or teaching amusement-park management skills to the people that run our hospitals.  Read More »
From the Corners of the World: Russia: Is the Bear Riding a Bull?
Paul Altaffer & Grant Washington-Smith
October 1, 2011
The Russian nutraceuticals market offers great potential but there are some significant risks that must be considered.  Read More »
Nutraceuticals Multiverse: Proprietary Puncture: Part I
Anthony Almada
October 1, 2011
Proprietary compositions and ‘blends’ enjoy partial insulation...but what if regulatory agencies and consumers could dereplicate them?  Read More »
Word from Wall Street: A Bit of Chaos & Randomness
Adam Ismail
October 1, 2011
Will nutraceuticals once again buck the broader economic trends?  Read More »
Business Insights: What a Difference a Decade Makes
Gregory Stephens, RD
September 1, 2011
The last 10 years have had a sizable impact on product development.  Read More »
Capitol Comments: Dissecting FDA’s NDI Guidance
Todd Harrison
September 1, 2011
Discussing the highlights of the new guidance and what it means for the supplement business.  Read More »
Eurotrends: The Silver Lining in Europe’s Claim Regulations
Joerg Gruenwald
September 1, 2011
There are plenty of ways to get the most out of Article 13.1 claims.  Read More »
Quality Focus: The Science of Quality: A Pharmacognosist’s Perspective
Joseph Betz, PhD
September 1, 2011
Researchers must know as much as possible about the nature and characteristics of the material they wish to study—period.  Read More »
Research Process: Research Matters
Douglas Kalman, PhD
September 1, 2011
Research should be figured into the cost of doing business in the supplement world, but it’s ok to start small.  Read More »
Nutraceuticals Multiverse: A Real Class Act(ion)
Anthony Almada
September 1, 2011
What if ‘consumer’ class action suits achieved more than just consumer redress?  Read More »
Word from Wall Street: Staying Positive
Adam Ismail
July 1, 2011
The Schiff-Ganeden acquisition proves that good deals can be made in a bad economy.  Read More »
Healthcare Practitioner Corner: Getting Off The (Disease) Plantation
Erik Goldman
July 1, 2011
Doctors are seeking real changes that will improve their patients’ lives and their own.  Read More »
From the Corners of the World: India: The Prowling Tiger
Paul Altaffer &nGrant Washington-Smith
July 1, 2011
India has moved center stage as an economy to watch and nutraceutical companies are ready to pounce.  Read More »
Nutraceuticals Multiverse: The Ethos of Ethics
Anthony Almada
July 1, 2011
What if consumers were able to query nutraceutical industry executives—and the executives were ‘inspired’ to tell the truth?  Read More »

Receive free Nutraceuticals World emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Nutraceuticals World On